Introduction
Placental transverse relaxation time (T2) assessed by MRI may have the potential to improve the antenatal identification of small for gestational age. The aims of this study were to provide normal values of placental T2 in relation to gestational age at the time of MRI and to explore the correlation between placental T2 and birthweight.
Material and methods
A mixed cohort of 112 singleton pregnancies was retrieved from our placental MRI research database. MRI was performed at 23.6‐41.3 weeks of gestation in a 1.5T system (TE (8): 50‐440 ms, TR: 4000 ms). Normal pregnancies were defined by uncomplicated pregnancies with normal obstetric outcome and birthweight deviation within ±1 SD of the expected for gestational age. The correlation between placental T2 and birthweight was investigated using the following outcomes; small for gestational age (birthweight ≤−2 SD of the expected for gestational age) and birthweight deviation (birthweight Z‐scores).
Results
In normal pregnancies (n = 27), placenta T2 showed a significant negative linear correlation with gestational age (r = −.91, P = .0001) being 184 ms ± 15.94 ms (mean ± SD) at 20 weeks of gestation and 89 ms ± 15.94 ms at 40 weeks of gestation. Placental T2 was significantly reduced among small‐for‐gestational‐age pregnancies (mean Z‐score −1.95, P < .001). Moreover, we found a significant positive correlation between placenta T2 deviation (Z‐score) and birthweight deviation (Z‐score) (R2 = .26, P = .0001).
Conclusions
This study provides normal values of placental T2 to be used in future studies on placental MRI. Placental T2 is closely related to birthweight and may improve the antenatal identification of small‐for‐gestational‐age pregnancies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.